A citation-based method for searching scientific literature

Brian B Liau, Cem Sievers, Laura K Donohue, Shawn M Gillespie, William A Flavahan, Tyler E Miller, Andrew S Venteicher, Christine H Hebert, Christopher D Carey, Scott J Rodig, Sarah J Shareef, Fadi J Najm, Peter van Galen, Hiroaki Wakimoto, Daniel P Cahill, Jeremy N Rich, Jon C Aster, Mario L Suvà, Anoop P Patel, Bradley E Bernstein. Cell Stem Cell 2017
Times Cited: 242



Sumaiyah K Rehman, Jennifer Haynes, Evelyne Collignon, Kevin R Brown, Yadong Wang, Allison M L Nixon, Jeffrey P Bruce, Jeffrey A Wintersinger, Arvind Singh Mer, Edwyn B L Lo, Cherry Leung, Evelyne Lima-Fernandes, Nicholas M Pedley, Fraser Soares, Sophie McGibbon, Housheng Hansen He, Aaron Pollet, Trevor J Pugh, Benjamin Haibe-Kains, Quaid Morris, Miguel Ramalho-Santos, Sidhartha Goyal, Jason Moffat, Catherine A O'Brien. Cell 2021
Times Cited: 96




List of shared articles



Times cited

Cell-Intrinsic Mechanisms of Drug Tolerance to Systemic Therapies in Cancer.
Camille Leonce, Pierre Saintigny, Sandra Ortiz-Cuaran. Mol Cancer Res 2022
2

Modulating environmental signals to reveal mechanisms and vulnerabilities of cancer persisters.
Xiaoxiao Sun, Jake M Bieber, Heinz Hammerlindl, Robert J Chalkley, Kathy H Li, Alma L Burlingame, Matthew P Jacobson, Lani F Wu, Steven J Altschuler. Sci Adv 2022
0

p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis.
Laura Solé, Teresa Lobo-Jarne, Daniel Álvarez-Villanueva, Josune Alonso-Marañón, Yolanda Guillén, Marta Guix, Irene Sangrador, Catalina Rozalén, Anna Vert, Antonio Barbachano,[...]. Nat Commun 2022
4

Persister state-directed transitioning and vulnerability in melanoma.
Heike Chauvistré, Batool Shannan, Sheena M Daignault-Mill, Robert J Ju, Daniel Picard, Stefanie Egetemaier, Renáta Váraljai, Christine S Gibhardt, Antonio Sechi, Farnusch Kaschani,[...]. Nat Commun 2022
2

Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer.
Celia Delahaye, Sarah Figarol, Anne Pradines, Gilles Favre, Julien Mazieres, Olivier Calvayrac. Cancers (Basel) 2022
2

Glutathione Peroxidase 4 as a Therapeutic Target for Anti-Colorectal Cancer Drug-Tolerant Persister Cells.
Xiaoli Zhang, Yiming Ma, Jianhui Ma, Lan Yang, Qingzhi Song, Hongying Wang, Guoqing Lv. Front Oncol 2022
1

Persister cells that survive chemotherapy are pinpointed.
Sumaiyah K Rehman, Catherine A O'Brien. Nature 2022
0

From Intestinal Epithelial Homeostasis to Colorectal Cancer: Autophagy Regulation in Cellular Stress.
Qiuluo Liu, Yan Chen, Li Zhou, Haining Chen, Zongguang Zhou. Antioxidants (Basel) 2022
0

Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer.
Kaixuan Shi, Haijiao Lu, Zhenfeng Zhang, Yujie Fu, Jie Wu, Shichao Zhou, Pengfei Ma, Kaiyan Ye, Shengzhe Zhang, Hailei Shi,[...]. Cell Death Differ 2022
0

Escape from G1 arrest during acute MEK inhibition drives the acquisition of drug resistance.
Prasanna Channathodiyil, Kieron May, Anne Segonds-Pichon, Paul D Smith, Simon J Cook, Jonathan Houseley. NAR Cancer 2022
0

Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells.
Giulia De Conti, Matheus Henrique Dias, René Bernards. Cancers (Basel) 2021
19

A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells.
Sarthak Sahoo, Ashutosh Mishra, Harsimran Kaur, Kishore Hari, Srinath Muralidharan, Susmita Mandal, Mohit Kumar Jolly. NAR Cancer 2021
16

Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy.
Masashi Mikubo, Yoshiaki Inoue, Geoffrey Liu, Ming-Sound Tsao. J Thorac Oncol 2021
12